Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125


FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary gland.

Isono Y, Furuya M, Kuwahara T, Sano D, Suzuki K, Jikuya R, Mitome T, Otake S, Kawahara T, Ito Y, Muraoka K, Nakaigawa N, Kimura Y, Baba M, Nagahama K, Takahata H, Saito I, Schmidt LS, Linehan WM, Kodama T, Yao M, Oridate N, Hasumi H.

Biochem Biophys Res Commun. 2019 Dec 2. pii: S0006-291X(19)32312-5. doi: 10.1016/j.bbrc.2019.11.184. [Epub ahead of print]


The Pretherapeutic Neutrophil-to-Lymphocyte Ratio for Docetaxel-Based Chemotherapy Is Useful for Predicting the Prognosis of Japanese Patients with Castration-Resistant Prostate Cancer.

Tatenuma T, Kawahara T, Hayashi N, Hasumi H, Makiyama K, Nakaigawa N, Kishida T, Miyoshi Y, Yao M, Uemura H.

Biomed Res Int. 2019 Oct 31;2019:2535270. doi: 10.1155/2019/2535270. eCollection 2019.


Successful Resection of Cisplatin-Resistant Renal Pelvic Cancer after the Administration of Pembrolizumab as Second-Line Therapy.

Kawahara T, Mochizuki T, Sugimura R, Izumi K, Kuroda S, Miyoshi Y, Nakaigawa N, Yao M, Tanabe M, Uemura H.

Case Rep Oncol. 2019 Jul 16;12(2):548-553. doi: 10.1159/000501715. eCollection 2019 May-Aug.


Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib.

Kawahara T, Takeshima T, Miyoshi Y, Nakaigawa N, Yao M, Tanabe M, Uemura H.

Case Rep Oncol. 2019 Jul 16;12(2):543-547. doi: 10.1159/000501716. eCollection 2019 May-Aug.


Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab.

Tabei T, Nakaigawa N, Kaneta T, Ikeda I, Kondo K, Makiyama K, Hasumi H, Hayashi N, Kawahara T, Izumi K, Osaka K, Muraoka K, Teranishi JI, Miyoshi Y, Yumura Y, Uemura H, Kobayashi K, Inoue T, Yao M.

BMC Cancer. 2019 Apr 2;19(1):298. doi: 10.1186/s12885-019-5510-y.


RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.

Kato I, Furuya M, Baba M, Kameda Y, Yasuda M, Nishimoto K, Oyama M, Yamasaki T, Ogawa O, Niino H, Nakaigawa N, Yano Y, Sakamoto K, Urata Y, Mikami K, Yamasaki S, Tanaka R, Takagi T, Kondo T, Nagashima Y.

Histopathology. 2019 Aug;75(2):254-265. doi: 10.1111/his.13866. Epub 2019 Jun 25.


PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer.

Kawahara T, Ishiguro Y, Ohtake S, Kato I, Ito Y, Ito H, Makiyama K, Kondo K, Miyoshi Y, Yumura Y, Hayashi N, Hasumi H, Osaka K, Muraoka K, Izumi K, Teranishi JI, Uemura H, Yao M, Nakaigawa N.

BMC Urol. 2018 Nov 6;18(1):97. doi: 10.1186/s12894-018-0414-8.


Sarcomatoid Variant of Bladder Carcinoma: A Case Report.

Uemura K, Kawahara T, Ishida H, Nakaigawa N, Tanabe M, Yao M, Uemura H.

Case Rep Oncol. 2018 Sep 13;11(3):633-637. doi: 10.1159/000492779. eCollection 2018 Sep-Dec.


Renal Cell Carcinoma in a Horseshoe Kidney Treated with Laparoscopic Partial Nephrectomy.

Ohtake S, Kawahara T, Noguchi G, Nakaigawa N, Chiba K, Uemura H, Yao M, Makiyama K.

Case Rep Oncol Med. 2018 Jun 7;2018:7135180. doi: 10.1155/2018/7135180. eCollection 2018.


Histopathological analysis of aggressive renal cell carcinoma harboring a unique germline mutation in fumarate hydratase.

Matsumoto K, Udaka N, Hasumi H, Nakaigawa N, Nagashima Y, Tanaka R, Kato I, Yao M, Furuya M.

Pathol Int. 2018 May 24. doi: 10.1111/pin.12684. [Epub ahead of print]


Primary amelanotic malignant melanoma of the male urethra with inguinal lymph node metastasis successfully controlled by nivolumab: A case report.

Tokita T, Kawahara T, Ito Y, Tsutsumi S, Abe K, Namura K, Sano F, Shioi K, Takamoto D, Yumura Y, Nakaigawa N, Yao M, Uemura H, Wada H, Tsuura Y, Kobayashi K.

Urol Case Rep. 2018 Mar 13;18:54-56. doi: 10.1016/j.eucr.2018.03.006. eCollection 2018 May.


BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genes.

Hasumi H, Furuya M, Tatsuno K, Yamamoto S, Baba M, Hasumi Y, Isono Y, Suzuki K, Jikuya R, Otake S, Muraoka K, Osaka K, Hayashi N, Makiyama K, Miyoshi Y, Kondo K, Nakaigawa N, Kawahara T, Izumi K, Teranishi J, Yumura Y, Uemura H, Nagashima Y, Metwalli AR, Schmidt LS, Aburatani H, Linehan WM, Yao M.

Hum Mol Genet. 2018 Aug 1;27(15):2712-2724. doi: 10.1093/hmg/ddy181.


Fluorescent Light-Guided Cystoscopy with 5-ALA Aids in Accurate Surgical Margin Detection for TURBO: A Case Report.

Takamoto D, Kawahara T, Ohtake S, Mochizuki T, Kuroda S, Nakaigawa N, Izumi K, Miyoshi Y, Makiyama K, Yao M, Sawazumi T, Inayama Y, Ohta J, Uemura H.

Case Rep Oncol. 2018 Mar 15;11(1):164-167. doi: 10.1159/000487390. eCollection 2018 Jan-Apr.


Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report.

Noguchi G, Tsutsumi S, Yasui M, Ohtake S, Umemoto S, Nakaigawa N, Yao M, Kishida T.

BMC Urol. 2018 Apr 18;18(1):26. doi: 10.1186/s12894-018-0339-2.


Time-dependent change in relapse sites of renal cell carcinoma after curative surgery.

Noguchi G, Nakaigawa N, Taguri M, Tsutsumi S, Saito Y, Fukui S, Yasui M, Tokita T, Mitome T, Tatenuma T, Kuroda S, Abe K, Ueno D, Namura K, Umemoto S, Takizawa A, Ohta J, Ueki T, Watanabe T, Kobayashi K, Kondo K, Kishida T, Kanno H, Kitami K, Yamanaka T, Yao M.

Clin Exp Metastasis. 2018 Feb;35(1-2):69-75. doi: 10.1007/s10585-018-9883-0. Epub 2018 Mar 7.


FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma.

Nakaigawa N, Kondo K, Kaneta T, Tateishi U, Minamimoto R, Namura K, Ueno D, Kobayashi K, Kishida T, Ikeda I, Hasumi H, Makiyama K, Hayashi N, Osaka K, Muraoka K, Izumi K, Kawahara T, Teranishi JI, Miyoshi Y, Yumura Y, Uemura H, Inoue T, Yao M.

Cancer Chemother Pharmacol. 2018 Apr;81(4):739-744. doi: 10.1007/s00280-018-3542-7. Epub 2018 Feb 20.


Complete Response to Sorafenib Rechallenge in a Patient with Metastatic Renal Cell Carcinoma.

Kasahara R, Nakaigawa N, Kobayashi K.

Case Rep Oncol Med. 2017;2017:2648471. doi: 10.1155/2017/2648471. Epub 2017 Sep 20.


Large cell neuroendocrine carcinoma of the kidney with cardiac metastasis: a case report.

Shimbori M, Osaka K, Kawahara T, Kasahara R, Kawabata S, Makiyama K, Kondo K, Nakaigawa N, Yamanaka S, Yao M.

J Med Case Rep. 2017 Oct 20;11(1):297. doi: 10.1186/s13256-017-1460-7.


A low psoas muscle volume correlates with a longer hospitalization after radical cystectomy.

Saitoh-Maeda Y, Kawahara T, Miyoshi Y, Tsutsumi S, Takamoto D, Shimokihara K, Hayashi Y, Mochizuki T, Ohtaka M, Nakamura M, Hattori Y, Teranishi JI, Yumura Y, Osaka K, Ito H, Makiyama K, Nakaigawa N, Yao M, Uemura H.

BMC Urol. 2017 Sep 18;17(1):87. doi: 10.1186/s12894-017-0279-2.


Modified C index: Novel predictor of postoperative renal functional loss of laparoscopic partial nephrectomy.

Ito H, Makiyama K, Kawahara T, Osaka K, Izumi K, Yokomizo Y, Nakaigawa N, Yao M.

Can Urol Assoc J. 2017 May;11(5):E215-E221. doi: 10.5489/cuaj.4192. Epub 2017 May 9.


A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.

Kasahara R, Kawahara T, Ohtake S, Saitoh Y, Tsutsumi S, Teranishi JI, Miyoshi Y, Nakaigawa N, Yao M, Kobayashi K, Uemura H.

Biomed Res Int. 2017;2017:7981549. doi: 10.1155/2017/7981549. Epub 2017 Apr 13.


One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.

Ito H, Kondo K, Kawahara T, Kaneta T, Tateishi U, Ueno D, Namura K, Kobayashi K, Miyoshi Y, Yumura Y, Makiyama K, Hayashi N, Hasumi H, Osaka K, Yokomizo Y, Teranishi JI, Hattori Y, Inoue T, Uemura H, Yao M, Nakaigawa N.

Cancer Chemother Pharmacol. 2017 May;79(5):855-861. doi: 10.1007/s00280-017-3275-z. Epub 2017 Mar 22.


The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy.

Nakaigawa N, Kondo K, Ueno D, Namura K, Makiyama K, Kobayashi K, Shioi K, Ikeda I, Kishida T, Kaneta T, Minamimoto R, Tateishi U, Inoue T, Yao M.

BMC Cancer. 2017 Jan 9;17(1):39. doi: 10.1186/s12885-016-3044-0.



Shimbori M, Nakaigawa N, Yokomizo Y, Kasahara R, Sato M, Hasumi H, Hayashi N, Makiyama K, Kondo K, Umeda S, Yao M.

Nihon Hinyokika Gakkai Zasshi. 2017;108(3):154-157. doi: 10.5980/jpnjurol.108.154. Japanese.



Kasahara R, Nakaigawa N, Yokomizo Y, Hasumi H, Hayashi N, Muraoka K, Takizawa A, Hibiya T, Yamanaka S, Nagashima Y, Yao M.

Nihon Hinyokika Gakkai Zasshi. 2017;108(3):149-153. doi: 10.5980/jpnjurol.108.149. Japanese.


H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation.

Hasumi H, Hasumi Y, Baba M, Nishi H, Furuya M, Vocke CD, Lang M, Irie N, Esumi C, Merino MJ, Kawahara T, Isono Y, Makiyama K, Warner AC, Haines DC, Wei MH, Zbar B, Hagenau H, Feigenbaum L, Kondo K, Nakaigawa N, Yao M, Metwalli AR, Marston Linehan W, Schmidt LS.

Hum Mol Genet. 2017 Jan 15;26(2):354-366. doi: 10.1093/hmg/ddw392.


Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.

Ohtake S, Kawahara T, Kasahara R, Ito H, Osaka K, Hattori Y, Teranishi JI, Makiyama K, Mizuno N, Umemoto S, Miyoshi Y, Nakaigawa N, Miyamoto H, Yao M, Uemura H.

Biomed Res Int. 2016;2016:9846823. Epub 2016 Sep 8.


Essential content of evidence-based clinical practice guidelines for bladder cancer: The Japanese Urological Association 2015 update.

Kubota Y, Nakaigawa N; Committee for Establishment of the Clinical Practice Guideline for the Management of Bladder Cancer and the Japanese Urological Association.

Int J Urol. 2016 Aug;23(8):640-5. doi: 10.1111/iju.13141. Epub 2016 Jul 3.


Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study.

Minamimoto R, Nakaigawa N, Nagashima Y, Toyohara J, Ueno D, Namura K, Nakajima K, Yao M, Kubota K.

Abdom Radiol (NY). 2016 Mar;41(3):521-30. doi: 10.1007/s00261-015-0601-y.


Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy.

Kawahara T, Furuya K, Nakamura M, Sakamaki K, Osaka K, Ito H, Ito Y, Izumi K, Ohtake S, Miyoshi Y, Makiyama K, Nakaigawa N, Yamanaka T, Miyamoto H, Yao M, Uemura H.

BMC Cancer. 2016 Mar 5;16:185. doi: 10.1186/s12885-016-2219-z.


FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma.

Nakaigawa N, Kondo K, Tateishi U, Minamimoto R, Kaneta T, Namura K, Ueno D, Kobayashi K, Kishida T, Ikeda I, Hasumi H, Makiyama K, Kubota Y, Inoue T, Yao M.

BMC Cancer. 2016 Feb 8;16:67. doi: 10.1186/s12885-016-2097-4.


Bilateral renal lymphoma: rapid recovery from an acute kidney injury after open renal biopsy.

Mitome T, Furuya K, Imano M, Osaka K, Yokomizo Y, Hayashi N, Nakaigawa N, Yamanaka S, Yao M.

Clin Case Rep. 2015 Oct 7;4(1):5-8. doi: 10.1002/ccr3.401. eCollection 2016 Jan.


Impact of Accidental Tumor Incision During Laparoscopic Partial Nephrectomy on the Oncologic and Clinical Outcomes.

Ito H, Makiyama K, Kawahara T, Osaka K, Izumi K, Yokomizo Y, Nakaigawa N, Yamanaka S, Yao M.

Clin Genitourin Cancer. 2016 Aug;14(4):e291-7. doi: 10.1016/j.clgc.2015.11.013. Epub 2015 Nov 26.


Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy.

Kawahara T, Fukui S, Sakamaki K, Ito Y, Ito H, Kobayashi N, Izumi K, Yokomizo Y, Miyoshi Y, Makiyama K, Nakaigawa N, Yamanaka T, Yao M, Miyamoto H, Uemura H.

Oncotarget. 2015 Oct 13;6(31):32169-76. doi: 10.18632/oncotarget.5081.


Predictors of trifecta outcomes in laparoscopic partial nephrectomy for clinical T1a renal masses.

Osaka K, Makiyama K, Nakaigawa N, Yao M.

Int J Urol. 2015 Nov;22(11):1000-5. doi: 10.1111/iju.12893. Epub 2015 Aug 6.


Validation of a patient-specific simulator for laparoscopic renal surgery.

Makiyama K, Yamanaka H, Ueno D, Ohsaka K, Sano F, Nakaigawa N, Yao M, Kubota Y.

Int J Urol. 2015 Jun;22(6):572-6. doi: 10.1111/iju.12737. Epub 2015 Feb 26.


Mucinous cystadenoma of a horseshoe kidney: A case report and literature review.

Mitome T, Yao M, Udaka N, Fusayasu S, Izumi K, Osaka K, Hayashi N, Nakaigawa N, Nagashima Y, Kubota Y.

Can Urol Assoc J. 2015 Jan-Feb;9(1-2):E30-2. doi: 10.5489/cuaj.2211.


[Pathological diagnosis of renal tumors: up to date].

Nagashima Y, Aoki I, Kondo K, Nakaigawa N, Kishida T, Miyagi Y, Yao M.

Rinsho Byori. 2014 Jun;62(6):568-77. Japanese.


The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ.

Kakizoe M, Yao M, Tateishi U, Minamimoto R, Ueno D, Namura K, Makiyama K, Hayashi N, Sano F, Kishida T, Kobayashi K, Noguchi S, Ikeda I, Ohgo Y, Taguri M, Morita S, Inoue T, Kubota Y, Nakaigawa N.

BMC Cancer. 2014 Jun 2;14:390. doi: 10.1186/1471-2407-14-390.


Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas.

Yao M, Murakami T, Shioi K, Mizuno N, Ito H, Kondo K, Hasumi H, Sano F, Makiyama K, Nakaigawa N, Kishida T, Nagashima Y, Yamanaka S, Kubota Y.

Cancer Med. 2014 Aug;3(4):845-54. doi: 10.1002/cam4.270. Epub 2014 May 26.


Laparoscopic nephroureterectomy for adult patient with primary obstructive megaureter.

Osaka K, Makiyama K, Ohtake S, Yamanaka H, Sano F, Nakaigawa N, Kubota Y.

Case Rep Urol. 2013;2013:124710. doi: 10.1155/2013/124710. Epub 2013 Dec 22.


Early ultrasonographic evaluation of tumor thrombus level during sunitinib therapy for renal cell carcinoma.

Sano F, Fusayasu S, Otake S, Yamanaka H, Tatenuma T, Sakata R, Makiyama K, Nakaigawa N, Yao M, Kubota Y.

J Med Ultrason (2001). 2013 Oct;40(4):463-5. doi: 10.1007/s10396-013-0448-1. Epub 2013 May 1.


[A case of metastatic renal cell carcinoma associated with Birt-Hogg-Dubé syndrome treated with molecular-targeting agents].

Nakamura M, Yao M, Sano F, Sakata R, Tatenuma T, Makiyama K, Nakaigawa N, Kubota Y.

Hinyokika Kiyo. 2013 Aug;59(8):503-6. Japanese.


[Vesical tuberculosis after Bacillus Calmette-Guerin intravesical instillation therapy for bladder cancer].

Ohtake S, Kawaji K, Nakaigawa N, Inayama Y, Kubota Y.

Hinyokika Kiyo. 2013 Jul;59(7):457-60. Japanese.


aPKCλ/ι is a beneficial prognostic marker for pancreatic neoplasms.

Kato S, Akimoto K, Nagashima Y, Ishiguro H, Kubota K, Kobayashi N, Hosono K, Watanabe S, Sekino Y, Sato T, Sasaki K, Nakaigawa N, Kubota Y, Inayama Y, Endo I, Ohno S, Maeda S, Nakajima A.

Pancreatology. 2013 Jul-Aug;13(4):360-8. doi: 10.1016/j.pan.2013.05.006. Epub 2013 May 22.


[Four cases of penile fracture].

Ohtake S, Nakaigawa N, Kubota Y.

Hinyokika Kiyo. 2013 Apr;59(4):251-5. Japanese.


Nonfunctioning juxtaglomerular cell tumor.

Sakata R, Shimoyamada H, Yanagisawa M, Murakami T, Makiyama K, Nakaigawa N, Inayama Y, Ohashi K, Nagashima Y, Yao M, Kubota Y.

Case Rep Pathol. 2013;2013:973865. doi: 10.1155/2013/973865. Epub 2013 Mar 27.


[A case of myocardiac metastasis of clear cell renal carcinoma successfully treated with sunitinib].

Tatenuma T, Yao M, Sakata R, Sano F, Makiyama K, Nakaigawa N, Nakayama T, Inayama Y, Kubota Y.

Hinyokika Kiyo. 2013 Feb;59(2):97-101. Japanese.


Comparison of the loss of renal function after cold ischemia open partial nephrectomy, warm ischemia laparoscopic partial nephrectomy and laparoscopic partial nephrectomy using microwave coagulation.

Kawahara T, Sakata R, Kawahara K, Ito H, Miyoshi Y, Sano F, Nakaigawa N, Uemura H, Yao M, Kubota Y, Makiyama K.

Curr Urol. 2013 Jan;6(3):118-23. doi: 10.1159/000343524. Epub 2012 Dec 21.

Supplemental Content

Loading ...
Support Center